.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Express Scripts
Daiichi Sankyo
Dow
McKesson
Baxter
Federal Trade Commission
Chinese Patent Office
Chubb

Generated: November 22, 2017

DrugPatentWatch Database Preview

TOLAZAMIDE Drug Profile

« Back to Dashboard

Which patents cover Tolazamide, and when can generic versions of Tolazamide launch?

Tolazamide is a drug marketed by Watson Labs, Sandoz, Usl Pharma, Sun Pharm Inds, Mylan Pharms Inc, Par Pharm, Barr, Superpharm, Duramed Pharms Barr, Interpharm, and G And W Labs Inc. and is included in thirty NDAs.

The generic ingredient in TOLAZAMIDE is tolazamide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tolazamide profile page.

Pharmacology for TOLAZAMIDE

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea

Medical Subject Heading (MeSH) Categories for TOLAZAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc
TOLAZAMIDE
tolazamide
TABLET;ORAL018894-002Nov 2, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Interpharm
TOLAZAMIDE
tolazamide
TABLET;ORAL071271-001Sep 23, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
TOLAZAMIDE
tolazamide
TABLET;ORAL018894-003Nov 2, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
TOLAZAMIDE
tolazamide
TABLET;ORAL070289-001Mar 13, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TOLAZAMIDE
tolazamide
TABLET;ORAL070513-001Jan 9, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
TOLAZAMIDE
tolazamide
TABLET;ORAL070163-001Jan 14, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms Barr
TOLAZAMIDE
tolazamide
TABLET;ORAL070167-001Jan 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TOLAZAMIDE
tolazamide
TABLET;ORAL070244-001Aug 1, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
TOLAZAMIDE
tolazamide
TABLET;ORAL071633-001Dec 9, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
TOLAZAMIDE
tolazamide
TABLET;ORAL070259-003Mar 17, 1986RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Covington
Federal Trade Commission
Express Scripts
Medtronic
Boehringer Ingelheim
QuintilesIMS
Cantor Fitzgerald
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot